Nanotechnology Based Approaches for Tuberculosis Treatment

Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.

1. Pathogenesis, biology, and immunology of tuberculosisRAVI BANDARU, DEVIPRASAD SAHOO, RAMAKANTA NAIK, PRASHANT KESHARWANI AND RAMBABU DANDELA2. Tuberculosis: introduction, drug regimens, and multidrug-resistanceSIMA SINGH, NEELAM DHANKAR, ASHISH KUMAR GARG AND PRASHANT KESHARWANI3. Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis DAMIÁN EDUARDO PÉREZ-MARTÍNEZ AND ROBERTO ZENTENO-CUEVAS4. Translational research for therapy against tuberculosis YOLANDA GONZALEZ, SILVIA GUZMÁN-BELTRÁN, LAURA E. CARRETO-BINAGHI AND ESMERALDA JUÁREZ5. Vaccine delivery systems against tuberculosis RUPAL OJHA, RAJAN KUMAR PANDEY AND VIJAY KUMAR PRAJAPATI6. Inhalable polymeric dry powders for antituberculosis drug delivery SUNEERA ADLAKHA, KALPESH VAGHASIYA, ANKUR SHARMA, EUPA RAY AND RAHUL KUMAR VERMA7. Liposomes-and niosomes-based drug delivery systems for tuberculosis treatmentALI IBRAHIM BEKRAKI8. Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis MOHSEN TAFAGHODI, FARZAD KHADEMI, FARIDEH SHIEHZADEH AND ZOHREH FIROZI9. Nanotechnology-based approaches for tuberculosis treatmentMOHAMAD MOSA MUBARAK AND ZAHOOR AHMAD10. Dendrimer-based drug delivery systems for tuberculosis treatmentRAHUL SHUKLA, AAKRITI SETHI, MAYANK HANDA, MRADUL MOHAN, PRASHANT KESHARWANI AND PUSHPENDRA K. TRIPATHI11. Polymeric micelle-based drug delivery systems for tuberculosis treatmentBAPI GORAIN, HIRA CHOUDHURY, SREENIVAS PATRO AND PRASHANT KESHARWANI12. Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatmentSIMONE PINTO CARNEIRO AND ORLANDO DAVID HENRIQUE DOS SANTOS13. DNA markers and nano-biosensing approaches for tuberculosis diagnosisAMAL RABTI, AMAL RAOUAFI AND NOUREDDINE RAOUAFI14. Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis Noorsuzana Mohd Shariff15. Nanotechnology approach in conquering anti-TB resistanceB.D. NOVITA